NARI241220C35000
- 12.30
- 0.000.00%
Inari Medical Newsroom
Express News | Inari Medical Inc : Leerink Partners Raises Target Price to $52 From $48
Inari Medical(NARI.US) Director Sells US$3.07 Million in Common Stock
Insider Sale: Director at $NARI (NARI) Sells 9,750 Shares
Form 144 | Inari Medical(NARI.US) Director Proposes to Sell 6.07 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Nov 18, $Inari Medical(NARI.US)$ Director WILLIAM HOFFMAN intends to sell 120K shares of its common stock on Nov 18, with a total market value of approximately $6.07 million.
Is Inari Medical (NARI) Trading at an Attractive Valuation?
Market Participants Recognise Inari Medical, Inc.'s (NASDAQ:NARI) Revenues Pushing Shares 31% Higher
Inari Medical to Participate in the Jefferies London Healthcare Conference
Inari Medical Insider Sold Shares Worth $2,002,000, According to a Recent SEC Filing
Truist Financial Maintains Inari Medical(NARI.US) With Hold Rating, Maintains Target Price $50
A Quick Look at Today's Ratings for Inari Medical(NARI.US), With a Forecast Between $50 to $74
Inari Medical PEERLESS Results Show Superiority Of FlowTriever Compared To Catheter-Directed Thrombolytics For Intermediate-Risk Pulmonary Embolism, Published In 'Circulation'; PEERLESS Met Its Primary Composite Endpoint
Corning Posts Upbeat Q3 Earnings, Joins Opera, Inari Medical, Incyte And Other Big Stocks Moving Higher On Tuesday
Inari Medical Up Over 15%, On Track for Largest Percent Increase Since August 2023 -- Data Talk
A Quick Look at Today's Ratings for Inari Medical(NARI.US), With a Forecast Between $48 to $86
Truist Raises Price Target on Inari Medical to $50 From $46, Keeps Hold Rating
Inari Medical Is Maintained at Neutral by Piper Sandler
Inari Medical Inc (NARI) Q3 2024 Earnings Call Highlights: Record Revenue and Raised Guidance ...
Express News | Needham Reiterates Hold on Inari Medical
Inari Medical Analyst Ratings
Express News | Inari Medical Inc : Piper Sandler Raises Target Price to $52 From $50